THE EFFECT OF IN VIVO APPLICATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN CYTOTOXIC T CELLS IN RHESUS MONKEYS
- 1 April 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 35 (4) , 374-377
- https://doi.org/10.1097/00007890-198304000-00022
Abstract
Rhesus monkeys were treated in vivo with monoclonal antibodies specific for human cytotoxic T cells. These antibodies reacted with rhesus lymphocytes as they do with human lymphocytes. Injection of a pool of monoclonal antibodies resulted in rapid elimination of the relevant T cell subpopulation from the circulation. Injection of a single monoclonal antibody did not result in elimination of the subpopulation, but the cells were coated with the injected monoclonal antibody. Injection of the single monoclonal antibody did not prolong the allogeneic skin graft. The rhesus monkey is apparently a useful model for testing antihuman monoclonal antibodies.This publication has 3 references indexed in Scilit:
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981
- Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.The Journal of Experimental Medicine, 1981
- The immunosuppressive effect of monoclonal anti‐Lyt‐1.1 antibodies in vivoEuropean Journal of Immunology, 1981